Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: A Pilot Randomized Controlled Trial

Conditions: Muscle Invasive Bladder Urothelial Carcinoma; Muscle-Invasive Bladder Carcinoma Interventions: Drug: gemcitabine; Drug: Cisplatin Sponsors: Yung NA; Pamela Youde Nethersole Eastern Hospital; Queen Mary Hospital, Hong Kong Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials